FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

19616411000001108: Mezavant XL 1200mg tablets (Doncaster Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Nov 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
66334401000001115 Mezavant XL 1200mg tablets (Doncaster Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
78242301000001115 Mezavant XL 1200mg tablets (DE Pharmaceuticals) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mezavant XL 1200mg tablets (Doncaster Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Doncaster Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Doncaster Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Doncaster Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Doncaster Pharmaceuticals Ltd) Is a Mesalazine 1.2g gastro-resistant modified-release tablets true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Doncaster Pharmaceuticals Ltd) Has active ingredient Mesalazine true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Doncaster Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Doncaster Pharmaceuticals Ltd) Has specific active ingredient Mesalazine true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Doncaster Pharmaceuticals Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Doncaster Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Doncaster Pharmaceuticals Ltd) Is a Mezavant XL true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Doncaster Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Doncaster Pharmaceuticals Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mezavant XL 1200mg tablets (Doncaster Pharmaceuticals Ltd) 60 tablet Has AMP True Mezavant XL 1200mg tablets (Doncaster Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start